Cigna Profits Hit Nearly $2 Billion Despite Rising Costs

The Cigna Group Reports Strong Third Quarter Earnings Despite Rising Costs

The Cigna Group has announced its third quarter financial results, showing a net income of nearly $2 billion despite challenges posed by increasing costs in the health plans it offers. This achievement underscores the company’s resilience and strategic positioning in the market.

Similar to its competitors in the health insurance sector, Cigna has been grappling with escalating medical expenses from its customers. The third quarter results revealed a continued rise in costs compared to the same period last year.

Cigna reported a medical cost ratio of 84.8% for the third quarter of 2025, up from 82.8% in the third quarter of 2024. This increase was attributed to factors such as individual and family plans business and higher stop-loss medical costs relative to the previous year.

Despite the uptick in costs, Cigna’s medical cost ratio remains lower than some of its industry peers, many of whom are experiencing ratios exceeding 90%. This distinction is significant as Cigna’s cost challenges differ from those faced by competitors primarily operating in government-subsidized health insurance segments like Medicaid and Medicare Advantage.

In a strategic move earlier this year, Cigna divested its Medicare businesses to Health Care Service Corp., a move aimed at streamlining its operations and focusing on core growth areas.

The company reported a net income of $1.9 billion, or $6.98 per share for the third quarter, a significant increase from the same period in 2024. This growth was driven by strong performance across its businesses and a focused execution of its growth strategy.

David M. Cordani, Chairman and CEO of The Cigna Group, expressed satisfaction with the quarterly results, highlighting the company’s diversified portfolio and strategic focus even in a dynamic market environment.

Revenue for the third quarter rose by 10% to $69.7 billion, primarily fueled by the performance of Evernorth Health Services, which includes the pharmacy benefit management company Express Scripts and specialty pharmacy Accredo. The growth in existing client relationships and specialty pharmacy services contributed significantly to the revenue increase.

Overall, Cigna’s strong financial performance in the third quarter underscores its resilience and strategic focus in navigating challenges while capitalizing on growth opportunities in the evolving healthcare landscape.